Advertisement
UK markets close in 21 minutes
  • FTSE 100

    8,139.45
    +60.59 (+0.75%)
     
  • FTSE 250

    19,821.25
    +219.27 (+1.12%)
     
  • AIM

    755.23
    +2.11 (+0.28%)
     
  • GBP/EUR

    1.1663
    +0.0007 (+0.06%)
     
  • GBP/USD

    1.2456
    -0.0055 (-0.44%)
     
  • Bitcoin GBP

    51,106.95
    +217.00 (+0.43%)
     
  • CMC Crypto 200

    1,329.83
    -66.71 (-4.77%)
     
  • S&P 500

    5,103.03
    +54.61 (+1.08%)
     
  • DOW

    38,187.67
    +101.87 (+0.27%)
     
  • CRUDE OIL

    83.59
    +0.02 (+0.02%)
     
  • GOLD FUTURES

    2,344.80
    +2.30 (+0.10%)
     
  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     
  • HANG SENG

    17,651.15
    +366.61 (+2.12%)
     
  • DAX

    18,166.06
    +248.78 (+1.39%)
     
  • CAC 40

    8,098.35
    +81.70 (+1.02%)
     

Why Tonix Pharmaceuticals Stock Dived by Over 31% Today

Why Tonix Pharmaceuticals Stock Dived by Over 31% Today

All stocks have bad days at least once in a while, but Monday for Tonix Pharmaceuticals (NASDAQ: TNXP) was one of the ugliest trading sessions in its history. The company's stock lost nearly one-third of its value after the company announced a financial engineering move that sent investors scrambling for the exits. Tonix announced Monday afternoon that it is effecting a 1-for-32 reverse split of its common stock.